111 related articles for article (PubMed ID: 24630279)
21. [Doping of performance horses with psychotropic drugs].
Jaeschke G
Dtsch Tierarztl Wochenschr; 1983 Feb; 90(2):59-64. PubMed ID: 6131808
[No Abstract] [Full Text] [Related]
22. Flawed attention-deficit/hyperactivity disorder medication comparison.
Adesman A
Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
[No Abstract] [Full Text] [Related]
23. [Treatment with central nervous system stimulants. Practical guidelines].
Hvolby A; Jørgensen JI
Ugeskr Laeger; 2004 Jan; 166(3):144-8. PubMed ID: 14870640
[No Abstract] [Full Text] [Related]
24. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
Newcorn JH; Donnelly C
Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
[No Abstract] [Full Text] [Related]
25. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
26. Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents.
Roman MW
Issues Ment Health Nurs; 2010 Aug; 31(8):548-9. PubMed ID: 20624025
[No Abstract] [Full Text] [Related]
27. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
28. [Drug treatment of school children with attention deficit and hyperactivity disorder].
Vik T; Grov B; Garåsen H
Tidsskr Nor Laegeforen; 2001 Aug; 121(19):2261-4. PubMed ID: 11571876
[TBL] [Abstract][Full Text] [Related]
29. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
Killeen MR
J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
[No Abstract] [Full Text] [Related]
30. The stimulants.
Wilens TE; Biederman J
Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
[TBL] [Abstract][Full Text] [Related]
31. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
32. ["The amphetamine treatment helped my child". Is it time to reevaluate Swedish practice in hyperactivity syndrome?].
Lakartidningen; 1996 Nov; 93(47):4307-8. PubMed ID: 8984302
[No Abstract] [Full Text] [Related]
33. Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.
Vaughan B; Kratochvil CJ
Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):941-55. PubMed ID: 23040908
[TBL] [Abstract][Full Text] [Related]
34. Managing ADHD.
Baren M
Contemp Pediatr; 1994 Dec; 11(12):29-30, 33-4, 37-8 passim. PubMed ID: 10150283
[TBL] [Abstract][Full Text] [Related]
35. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
[TBL] [Abstract][Full Text] [Related]
36. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
37. [Central nervous system stimulants in AD/HD in adults].
Aanonsen NO; Lensing MB; Mathiesen T
Tidsskr Nor Laegeforen; 1999 Jan; 119(1):82-3. PubMed ID: 10025211
[No Abstract] [Full Text] [Related]
38. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
39. Attention-deficit/hyperactivity disorder: is it common? Is it overtreated?
Wender EH
Arch Pediatr Adolesc Med; 2002 Mar; 156(3):209-10. PubMed ID: 11876662
[No Abstract] [Full Text] [Related]
40. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
